Latest Insider Transactions at Celldex Therapeutics, Inc. (CLDX)
This section provides a real-time view of insider transactions for Celldex Therapeutics, Inc. (CLDX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Celldex Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Celldex Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2024
|
James J Marino |
SELL
Bona fide gift
|
Direct |
10,500
-82.65%
|
-
|
|
Nov 11
2024
|
Anthony S Marucci PRESIDENT & CEO |
BUY
Open market or private purchase
|
Direct |
11,500
+22.21%
|
$299,000
$26.82 P/Share
|
|
Jun 14
2024
|
Samuel Bates Martin SVP AND CFO |
SELL
Open market or private sale
|
Direct |
17,172
-37.91%
|
$601,020
$35.42 P/Share
|
|
Jun 14
2024
|
Samuel Bates Martin SVP AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,169
+18.7%
|
$181,521
$9.7 P/Share
|
|
Jun 14
2024
|
Elizabeth Crowley SR. VP & CPDO |
SELL
Open market or private sale
|
Direct |
30,000
-76.78%
|
$1,020,000
$34.87 P/Share
|
|
Jun 14
2024
|
Elizabeth Crowley SR. VP & CPDO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+43.43%
|
$300,000
$10.38 P/Share
|
|
Jun 11
2024
|
Diane C. Young SVP, CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+46.71%
|
$30,000
$2.71 P/Share
|
|
Jun 07
2024
|
Diane C. Young SVP, CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
45,000
-95.51%
|
$1,575,000
$35.26 P/Share
|
|
Jun 07
2024
|
Elizabeth Crowley SR. VP & CPDO |
SELL
Open market or private sale
|
Direct |
15,000
-62.31%
|
$525,000
$35.06 P/Share
|
|
Jun 07
2024
|
Elizabeth Crowley SR. VP & CPDO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+27.45%
|
$135,000
$9.7 P/Share
|
|
Jun 05
2024
|
Freddy A. Jimenez SVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
9,540
+21.2%
|
$95,400
$10.38 P/Share
|
|
Jun 03
2024
|
Freddy A. Jimenez SVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
8,006
-23.6%
|
$264,198
$33.6 P/Share
|
|
Jun 03
2024
|
Freddy A. Jimenez SVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
8,006
+19.09%
|
$80,060
$10.38 P/Share
|
|
Jun 03
2024
|
Richard M. Wright SR. VP & CCO |
SELL
Open market or private sale
|
Direct |
46,844
-44.4%
|
$1,545,852
$33.76 P/Share
|
|
Jun 03
2024
|
Richard M. Wright SR. VP & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
67,469
+35.9%
|
$1,146,973
$17.75 P/Share
|
|
Jun 03
2024
|
Margo Heath Chiozzi SVP OF REGULATORY AFFAIRS |
SELL
Open market or private sale
|
Direct |
58,369
-81.35%
|
$1,926,177
$33.65 P/Share
|
|
Jun 03
2024
|
Margo Heath Chiozzi SVP OF REGULATORY AFFAIRS |
BUY
Exercise of conversion of derivative security
|
Direct |
64,658
+38.41%
|
$581,922
$9.7 P/Share
|
|
May 30
2024
|
Sarah Cavanaugh SVP OF CORP AFFAIRS & ADMIN. |
SELL
Open market or private sale
|
Direct |
20,853
-91.81%
|
$688,149
$33.73 P/Share
|
|
May 30
2024
|
Sarah Cavanaugh SVP OF CORP AFFAIRS & ADMIN. |
BUY
Exercise of conversion of derivative security
|
Direct |
20,853
+38.4%
|
$104,265
$5.9 P/Share
|
|
May 30
2024
|
Samuel Bates Martin SVP AND CFO |
SELL
Open market or private sale
|
Direct |
35,000
-58.21%
|
$1,190,000
$34.05 P/Share
|
|
May 30
2024
|
Samuel Bates Martin SVP AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+29.37%
|
$250,000
$10.38 P/Share
|
|
May 30
2024
|
Margo Heath Chiozzi SVP OF REGULATORY AFFAIRS |
SELL
Open market or private sale
|
Direct |
38,719
-84.52%
|
$1,316,446
$34.07 P/Share
|
|
May 30
2024
|
Margo Heath Chiozzi SVP OF REGULATORY AFFAIRS |
BUY
Exercise of conversion of derivative security
|
Direct |
33,719
+17.1%
|
$236,033
$7.39 P/Share
|
|
May 30
2024
|
Elizabeth Crowley SR. VP & CPDO |
SELL
Open market or private sale
|
Direct |
38,597
-80.97%
|
$1,273,701
$33.64 P/Share
|
|
May 30
2024
|
Elizabeth Crowley SR. VP & CPDO |
BUY
Exercise of conversion of derivative security
|
Direct |
42,945
+30.96%
|
$214,725
$5.9 P/Share
|
|
Feb 13
2024
|
Freddy A. Jimenez SVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
24,166
+42.42%
|
$120,830
$5.9 P/Share
|
|
Jan 02
2024
|
Samuel Bates Martin SVP AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,750
+23.43%
|
$21,500
$2.78 P/Share
|
|
Dec 07
2022
|
Tibor Keler EXECUTIVE VP & CSO |
SELL
Open market or private sale
|
Direct |
16,860
-69.62%
|
$606,960
$36.93 P/Share
|
|
Dec 07
2022
|
Tibor Keler EXECUTIVE VP & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,860
+41.04%
|
$33,720
$2.78 P/Share
|
|
Aug 18
2022
|
Sarah Cavanaugh SVP OF CORP AFFAIRS & ADMIN. |
SELL
Open market or private sale
|
Direct |
1,355
-51.35%
|
$48,780
$36.38 P/Share
|
|
Aug 18
2022
|
Sarah Cavanaugh SVP OF CORP AFFAIRS & ADMIN. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,355
+33.93%
|
$12,195
$9.02 P/Share
|
|
Aug 17
2022
|
Diane C. Young SVP, CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
64,000
+48.11%
|
$384,000
$6.55 P/Share
|
|
Aug 17
2022
|
Diane C. Young SVP, CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
19,000
-89.98%
|
$703,000
$37.3 P/Share
|
|
Aug 17
2022
|
Sarah Cavanaugh SVP OF CORP AFFAIRS & ADMIN. |
SELL
Open market or private sale
|
Direct |
31,312
-96.06%
|
$1,127,232
$36.73 P/Share
|
|
Aug 17
2022
|
Sarah Cavanaugh SVP OF CORP AFFAIRS & ADMIN. |
BUY
Exercise of conversion of derivative security
|
Direct |
31,312
+49.0%
|
$62,624
$2.78 P/Share
|
|
Aug 15
2022
|
Anthony S Marucci PRESIDENT & CEO |
SELL
Open market or private sale
|
Direct |
120,000
-81.25%
|
$4,440,000
$37.66 P/Share
|
|
Aug 15
2022
|
Anthony S Marucci PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
120,000
+32.78%
|
$600,000
$5.9 P/Share
|
|
Aug 15
2022
|
Richard M. Wright SR. VP & CCO |
SELL
Open market or private sale
|
Direct |
15,328
-98.66%
|
$567,136
$37.71 P/Share
|
|
Aug 15
2022
|
Richard M. Wright SR. VP & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,328
+49.66%
|
$153,280
$10.38 P/Share
|
|
Aug 12
2022
|
Samuel Bates Martin SVP AND CFO |
SELL
Open market or private sale
|
Direct |
17,547
-15.42%
|
$614,145
$35.59 P/Share
|
|
Aug 12
2022
|
Samuel Bates Martin SVP AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,547
+18.33%
|
$87,735
$5.9 P/Share
|
|
Aug 11
2022
|
Samuel Bates Martin SVP AND CFO |
SELL
Open market or private sale
|
Direct |
2,453
-9.14%
|
$90,761
$37.04 P/Share
|
|
Aug 11
2022
|
Samuel Bates Martin SVP AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,453
+8.38%
|
$22,077
$9.02 P/Share
|
|
Dec 23
2021
|
Samuel Bates Martin SVP AND CFO |
SELL
Open market or private sale
|
Direct |
9,500
-28.04%
|
$399,000
$42.0 P/Share
|
|
Dec 23
2021
|
Samuel Bates Martin SVP AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+9.85%
|
$35,000
$5.9 P/Share
|
|
Dec 08
2021
|
Margo Heath Chiozzi SVP OF REGULATORY AFFAIRS |
SELL
Open market or private sale
|
Direct |
600
-5.06%
|
$24,000
$40.0 P/Share
|
|
Dec 08
2021
|
Margo Heath Chiozzi SVP OF REGULATORY AFFAIRS |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+4.82%
|
$1,200
$2.78 P/Share
|
|
Dec 08
2021
|
Elizabeth Crowley SR. VP & CPDO |
SELL
Open market or private sale
|
Direct |
4,000
-45.84%
|
$160,000
$40.0 P/Share
|
|
Dec 08
2021
|
Elizabeth Crowley SR. VP & CPDO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+31.43%
|
$36,000
$9.02 P/Share
|
|
Dec 08
2021
|
Sarah Cavanaugh SVP OF CORP AFFAIRS & ADMIN. |
SELL
Open market or private sale
|
Direct |
7,323
-94.72%
|
$292,920
$40.0 P/Share
|